Schedule 13D ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2018-11-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
882,818
Percent of class
4.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-074499
Form type
SC 13D/A
Filer
Decoy Therapeutics Inc.
CIK
CIK 1615219
Filed
Dec 21, 2018
Reporting period
Nov 06, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub